Explore the SS:600572 financials. Find the Zhejiang CONBA Pharm financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key ...

SHANGHAI and CAIRO, June 30, 2025 (GLOBE NEWSWIRE) -- EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East and Africa, and Zhejiang ...

HONG KONG – China's Zhejiang Conba Pharmaceutical Co. Ltd. is working on a ¥960 million (US$138.3 million) plan to focus on foreign investment and take biosimilar maker Genor Biopharma Co. Ltd. public ...

Evotec has licensed an early-stage inflammatory to Conba Pharmaceutical Co, one of China's largest drugmakers. Evotec has licensed an early-stage inflammatory to Conba Pharmaceutical Co, one of ...

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent ...

Two Regional Powerhouses to Strengthen Cross-Border Collaboration for a More Resilient and Accessible Healthcare Supply Chain SHANGHAI and CAIRO, June 30, 2025 (GLOBE NEWSWIRE) -- EVA Pharma, one of ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Zhejiang CONBA Pharmaceutical Co Ltd Company Profile Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...